CoChat

Fish Oil for the Treatment of Cardiovascular Disease

Open access

The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.

Abstract

Omega-3 fatty acids, which are found abundantly in fish oil, are increasingly being used in the management of cardiovascular disease. It is clear that fish oil, in clinically used doses (typically 4 g/d of eicosapentaenoic acid and docosahexaenoic acid) reduce high triglycerides. However, the role of omega-3 fatty acids in reducing mortality, sudden death, arrhythmias, myocardial infarction, and heart failure has not yet been established. This review will focus on the current clinical uses of fish oil and provide an update on their effects on triglycerides, coronary artery disease, heart failure, and arrhythmia. We will explore the dietary sources of fish oil as compared with drug therapy, and discuss the use of fish oil products in combination with other commonly used lipid-lowering agents. We will examine the underlying mechanism of fish oil's action on triglyceride reduction, plaque stability, and effect in diabetes, and review the newly discovered anti-inflammatory effects of fish oil. Finally, we will examine the limitations of current data and suggest recommendations for fish oil use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/crd.0b013e3181ea0de0

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Frishman WH Sonnenblick EH Sica DA Cardiovascular Pharmacotherapeutics 2 New York, NY McGraw Hill 2003 382

Cited by

See all 138

Metadata

Authors
Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z.
Affiliations
NYU Langone Health (US)
Corresponding author
Weitz, Daniel
Venue
Cardiology in Review
Published
2010-09
Volume
18
Issue
5
Pages
258-263
ISSN
1061-5377 (ISSN-L)
OpenAlex
W2036364822
Cited by
138
References
88
Citations by year
2026: 2 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 10 · 2019: 4 · 2018: 9 · 2017: 12 · 2016: 8 · 2015: 14 · 2014: 11 · 2013: 16 · 2012: 10
FWCI
1.22
Type
journal article
Language
en
Open access
Locations
  • Cardiology in Review (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01 HL58541, R01HL058541)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Physical Sciences › Chemistry › Organic Chemistry › Edible Oils Quality and Analysis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
fish oil, omega-3 fatty acids, cardiovascular disease, triglyceride lowering, coronary artery disease, heart failure, cardiac arrhythmias, sudden cardiac death, myocardial infarction, plaque stability, diabetes mellitus, anti-inflammatory activity, lipid-lowering drugs, eicosapentaenoic acid, docosahexaenoic acid
MeSH terms
Hypolipidemic Agents, Arrhythmias, Cardiac, Cardiovascular Diseases, Diabetes Mellitus, Fish Oils, Heart Failure, Humans, Fenofibrate, Triglycerides, United States, Fatty Acids, Omega-3, Death, Sudden, Cardiac, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.